D. Lesage
- Infectious Diseases top 10%
- Epidemiology
- Virology top 10%
- Molecular Medicine top 5%
- Molecular Biology
- Co-authors
- Jean‐Claude PetitV. LalandeY ChabbertG GerbaudFrédéric BarbutLaurence VergneEka Esu-WilliamsÉric Delaporte
- Topics
- Antibiotic Resistance in Bacteria (15 papers)Antibiotics Pharmacokinetics and Efficacy (11 papers)Pneumonia and Respiratory Infections (8 papers)
In The Last Decade
D. Lesage
26 papers receiving 288 citations
Peers
Comparison fields: 5 of 50
- Infectious Diseases 170
- Epidemiology 134
- Virology 77
- Molecular Medicine 76
- Molecular Biology 52
Countries citing papers authored by D. Lesage
This map shows the geographic impact of D. Lesage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Lesage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Lesage more than expected).
Fields of papers citing papers by D. Lesage
This network shows the impact of papers produced by D. Lesage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Lesage. The network helps show where D. Lesage may publish in the future.
Co-authorship network of co-authors of D. Lesage
This figure shows the co-authorship network connecting the top 25 collaborators of D. Lesage. A scholar is included among the top collaborators of D. Lesage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Lesage. D. Lesage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Fluoroquinolones dans les infections urinaires :évaluation des prescriptions à l’hôpital Saint-Antoine | 2 |
| 2 | 77 | |
| 3 | 37 | |
| 4 | Killing kinetics of RP 59500 and pristinamycin against penicillin-resistant pneumococci. | 3 |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 22 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | [Rhodococcus equi pneumonia: 1st opportunistic manifestation in a patient infected with HIV-1]. | 2 |
| 12 | [Cryptococcal hygroma of the elbow. Spontaneous mycological remission]. | 1 |
| 13 | [A case of severe colitis with positive hemocultures for Shigella flexneri]. | 2 |
| 14 | 5 | |
| 15 | [Comparative bactericidal activity of cefsulodin and ceftazidime on Pseudomonas aeruginosa]. | 1 |
| 16 | [Comparison of in vitro bacteriostatic effect of five betalactamins against Pseudomonas aeruginosa (author's transl)]. | 2 |
| 17 | 2 | |
| 18 | Bactéries du groupe Bacteroides fragilis. Mise en évidence par immunofluorescence dans les produits pathologiques. | 1 |
| 19 | 6 | |
| 20 | Carte génétique et strucutre chez Escherichia coli K12 d'un plasmide de résistance isolé de Salmonella ordonez | 14 |
About D. Lesage
D. Lesage is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Microbiology, having authored 33 papers that have together received 307 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Pneumonia and Respiratory Infections (8 papers). The work is most often cited by research in Virology (77 citations), Molecular Medicine (76 citations) and Infectious Diseases (170 citations). D. Lesage has collaborated with scholars based in France and Belgium. Frequent co-authors include Jean‐Claude Petit, V. Lalande, Y Chabbert, G Gerbaud, Frédéric Barbut, Laurence Vergne, Eka Esu-Williams, Éric Delaporte, Céline Montavon and Claire Mulanga-Kabeya. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Intensive Care Medicine and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.